JoVE Logo

Iniciar sesión

7.20 : Model Approaches for Pharmacokinetic Data: Physiological Models

Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue drug concentration can be mathematically expressed, with Cart and Cven representing the arterial and venous blood drug concentrations, respectively.

Physiological models can be categorized into blood-flow-limited models and diffusion-limited models. In a blood-flow-limited model, drug distribution is primarily regulated by blood flow to the tissue. In contrast, in a diffusion-limited model, the diffusion rate across tissue barriers predominantly controls drug distribution.

The advantages of these models lie in their ability to enhance understanding of complex drug interactions within the body, providing valuable insights for pharmacokinetic studies. Equations such as those expressing the rate of change in tissue drug concentration play a crucial role in quantitatively understanding the dynamics of drug distribution within physiological models. Overall, physiological models in pharmacokinetics serve as powerful tools for understanding the intricate processes involved in drug distribution and elimination within the human body, offering valuable insights for pharmaceutical research and development.

Tags

PharmacokineticsPhysiological ModelsDrug DistributionDrug EliminationDrug UptakePartition CoefficientBlood Flow RateTissue Drug ConcentrationBlood flow limited ModelsDiffusion limited ModelsDrug InteractionsPharmacokinetic StudiesPharmaceutical Research

Del capítulo 7:

article

Now Playing

7.20 : Model Approaches for Pharmacokinetic Data: Physiological Models

Pharmacokinetic Models

23 Vistas

article

7.1 : Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Pharmacokinetic Models

66 Vistas

article

7.2 : Model Approaches for Pharmacokinetic Data: Compartment Models

Pharmacokinetic Models

61 Vistas

article

7.3 : One-Compartment Open Model for IV Bolus Administration: General Considerations

Pharmacokinetic Models

125 Vistas

article

7.4 : One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

Pharmacokinetic Models

142 Vistas

article

7.5 : One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Pharmacokinetic Models

48 Vistas

article

7.6 : One-Compartment Model: IV Infusion

Pharmacokinetic Models

129 Vistas

article

7.7 : One-Compartment Open Model for Extravascular Administration: Zero-Order Absorption Model

Pharmacokinetic Models

45 Vistas

article

7.8 : One-Compartment Open Model for Extravascular Administration: First-Order Absorption Model

Pharmacokinetic Models

175 Vistas

article

7.9 : One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

Pharmacokinetic Models

257 Vistas

article

7.10 : One-Compartment Open Model: Urinary Excretion Data and Determination of k

Pharmacokinetic Models

102 Vistas

article

7.11 : Multicompartment Models: Overview

Pharmacokinetic Models

70 Vistas

article

7.12 : Two-Compartment Open Model: Overview

Pharmacokinetic Models

82 Vistas

article

7.13 : Two-Compartment Open Model: IV Bolus Administration

Pharmacokinetic Models

284 Vistas

article

7.14 : Two-Compartment Open Model: IV Infusion

Pharmacokinetic Models

178 Vistas

See More

JoVE Logo

Privacidad

Condiciones de uso

Políticas

Investigación

Educación

ACERCA DE JoVE

Copyright © 2025 MyJoVE Corporation. Todos los derechos reservados